The “magic weight loss drug”, Ozempic, will be sold in Uruguay since the MSP authorized registration
The injectable drug that improves blood sugar levels in adults with type 2 diabetes has been made popular by celebrities who use it.
The Ministry of Public Health (MSP) authorized last Friday the registration and sale of Ozempic, a drug known throughout the world as “the magic drug for weight loss” and for treating type 2 diabetes, reported Underlined with the Undersecretary of Public Health, José Luis Satdjian.
Thus, this Friday “the registration process was completed,” the official reported. The laboratory’s website states that the drug“along with diet and exercise, it improves blood sugar levels in adults with type 2 diabetes.” It also indicates that “in adults with type 2 diabetes and confirmed heart disease, Ozempic reduces the risk of major cardiovascular events such as stroke, heart attack, or death.” “You may also lose some weight,” it clarifies.
Ozempic, an injectable from MegaLabs, has gained enormous popularity for its weight loss effects, both among the Hollywood elite and among the rest of the population, despite its high price and its possible side effects, which have not yet been sufficiently studied.
One of the effects of this drug, which belongs to a group known as GLP-1 agonists, is that it transmits the feeling of satiety after eating, he said. EFE.
The popularity of the product reached Uruguay, where the population uses the injectable, which until last Friday was not authorized in the country, and sought to import them from neighboring countries: Argentina and Brazil. With information from EFE
